mirtazapine has been researched along with Excessive Periodic Sleep-Related Leg Movements in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine is a Food and Drug Administration-approved atypical antidepressant used off-label for insomnia." | 1.91 | A 9-year-old female with iron deficiency has severe periodic limb movements while taking mirtazapine for insomnia. ( Hawkins, M, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawkins, M | 1 |
| Fulda, S | 1 |
| Kloiber, S | 1 |
| Dose, T | 1 |
| Lucae, S | 1 |
| Holsboer, F | 1 |
| Schaaf, L | 1 |
| Hennings, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 1 Study of Mirtazapine in Healthy Subjects[NCT00878540] | Phase 1 | 12 participants (Anticipated) | Interventional | 2008-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for mirtazapine and Excessive Periodic Sleep-Related Leg Movements
| Article | Year |
|---|---|
Mirtazapine provokes periodic leg movements during sleep in young healthy men.
Topics: Adult; Age Factors; Antidepressive Agents, Tricyclic; Body Mass Index; Cohort Studies; Drug Administ | 2013 |
1 other study available for mirtazapine and Excessive Periodic Sleep-Related Leg Movements
| Article | Year |
|---|---|
A 9-year-old female with iron deficiency has severe periodic limb movements while taking mirtazapine for insomnia.
Topics: Adult; Child; Female; Humans; Iron; Iron Deficiencies; Mirtazapine; Nocturnal Myoclonus Syndrome; Re | 2023 |